Semaglutide is an FDA-approved injectable medication that mimics a hormone called GLP-1 (glucagon-like peptide-1)
Originally developed for managing blood glucose levels in people with type 2 diabetes, GLP-1 receptor agonists like Ozempic have demonstrated impressive results in supporting healthy weight loss
Wells said when these medications are injected, theyre not delivered to the body in a steady, natural way, which may cause certain hormones to interfere with sleep
Each patients protocol must be carefully individualized based on their unique health profile, goals, and response to treatment
Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial
Purpose: item } Purpose: item } Purpose: item }